Bone cements based on magnesium phosphates such as newberyite (N; MgHPO4.3H2O) have been shown as potential bone substitutes due to their biocompatibility, biodegradability and ability to support osteoblast differentiation and proliferation. Newberyite can hydrolyze to hydrated magnesium phosphate compounds (e.g. bobierite (Mg3(PO4)2.8H2O)) at alkaline conditions. In this study, 25 and 50 wt% of crystalline β -wollastonite (woll; CaSiO3) was admixed to newberyite powder in order to both enhance the acid-base hydrolysis of newberyite and to produce a functional bone cement. The setting process of wollastonite/newberyite cement mixtures started with the hydrolysis of the wollastonite with further transformation of newberyite into bobierite and the formation of magnesium silicate phase. The results demonstrated that 25 wollastonite/newberyite and 50 wollastonite/newberyite cement pastes at optimal powder/liquid ratios had final setting times of ∼34 and 25 min and compressive strength values of 18 and 32 MPa after seven days setting, respectively. The tests of cytotoxicity of cement extracts on osteoblastic cells and contact cytotoxicity of the cement substrates showed different results. The osteoblasts cultured in cement extracts readily proliferated which confirmed the non-cytotoxic concentration of ions released from both cements. On the other hand, a strong cytotoxic character of 25 wollastonite/newberyite sample surface in contrary to high (∼80%) proliferation activity of cells on the 50 wollastonite/newberyite cement substrate was observed. The differences in cell proliferation activity was attributed to different surface topographies of cement substrates, where needle-like precipitated microcrystals of magnesium phosphate phase (in 25 wollastonite/newberyite cement) prevented the adhesion and proliferation of osteoblasts contrary to the smoother surface covered by extremely fine nanoparticles in the 50 wollastonite/newberyite cement.
ZhangJLiuWSchnitzlerVet al.Calcium phosphate cements for bone substitution: chemistry, handling and mechanical properties. Acta Biomater2014; 10: 1035–1049.
2.
VaishyaRChauhanMVaishA. Bone cement. J Clin Orthop Trauma2013; 4: 157–163.
3.
GaoCWeiDYangHet al.Nanotechnology for treating osteoporotic vertebral fractures. Int J Nanomed2015; 10: 5139–5157.
4.
OhtsukiCMiyazakiTKyomotoMet al.Development of bioactive PMMA-based cement by modification with alkoxysilane and calcium salt. J Mater Sci Mater Med2001; 12: 895–899.
5.
AmbardAJMueninghoffL. Calcium phosphate cement: review of mechanical and biological properties. J Prosthodont2006; 15: 321–328.
6.
NiuLJiaoKWangTet al.A review of the bioactivity of hydraulic calcium silicate cements. J Dent2014; 42: 517–533.
7.
UnossonJEngqvistH. 2014. Development of a resorbable calcium phosphate cement with load bearing capacity. Bioceram Dev Appl2014; 4: 1–4.
8.
EngqvistHEdlundSGomez-OrtegaGet al.In vitro mechanical properties of a calcium silicate based bone void filler. Key Eng Mater2006; 309–311: 829–832.
9.
ZhangJLiuWSchnitzlerVet al.Calcium phosphate cements for bone substitution: Chemistry, handling and mechanical properties. Acta Biomater2014; 10: 1035–1049.
10.
BoseSFieldingGTarafderSet al.Trace element doping in calcium phosphate ceramics to Understand osteogenesis and angiogenesis. Trends Biotechnol2013; 31: 1–15.
11.
HeLYZhangXMLiuBet al.Effect of magnesium ion on human osteoblast activity. Braz J Med Biol Res2016; 49: 1–6.
12.
MestresGGinebraMP. Novel magnesium phosphate cements with high early strength and antibacterial properties. Acta Biomater2011; 7: 1853–1861.
13.
KlammertUIgnatiusAWolframUet al.In vivo degradation of low temperature calcium and magnesium phosphate ceramics in a heterotopic model. Acta Biomater2011; 7: 3469–3475.
14.
MosekeCSaratsisVGbureckU. Injectability and mechanical properties of magnesium phosphate cements. J Mater Sci Mater Med2011; 22: 2591–2598.
15.
CoeFLEvanAWorcesterE. Kidney stone disease. J Clin Invest2005; 115: 2598–2608.
16.
KlammertUReutherTBlankMet al.Phase composition, mechanical performance and in vitro biocompatibility of hydraulic setting calcium magnesium phosphate cements. Acta Biomater2010; 6: 1529–1535.
17.
AlkhraisatMHCabrejos-AzamaJRodríguezCRet al.Magnesium substitution in brushite cements. Mater Sci Eng C2013; 33: 475–481.
18.
ZhouHAgarwalAKGoelVKet al.Microwave assisted preparation of magnesium phosphate cement (MPC) for orthopedic applications: a novel solution to the exothermicity problem. Mater Sci Eng C2013; 33: 4288–4294.
19.
YuYXuCDaiH. Preparation and characterization of a degradable magnesium phosphate bone cement. Regen Biomater2016; 4: 231–237.
20.
ChenYWHsuTTWangKet al.Preparation of the fast setting and degrading Ca–Si–Mg cement with both odontogenesis and angiogenesis differentiation of human periodontal ligament cells. Mater Sci Eng C2016; 60: 374–383.
21.
ChristelTChristSBarraletJEet al.Chelate bonding mechanism in a novel magnesium phosphate bone cement. J Am Ceram Soc2015, pp. 1–4.
22.
DriessensFCMBoltongMGZapateroMIet al.In vivo behavior of three calcium phosphate cements and magnesium phosphate cement. J Mater Sci Mater Med1995; 6: 272–278.
23.
WaselauMSamiiVFWeisbrodeSEet al.Effects of a magnesium adhesive cement on bone stability and healing following a metatarsal osteotomy in horses. Am J Vet Res2007; 68: 370–378.
24.
KlammertUIgnatiusAWolframUet al.In vivo degradation of low temperature calcium and magnesium phosphate ceramics in a heterotopic model. Acta Biomater2011; 7: 3469–3475.
25.
DuffEJ. Orthophosphates. Part VIII. The transformation of newberryite into bobierrite in aqueous alkaline solutions. J Chem Soc A1971, pp. 2736–2740.
26.
DawoodAEParashosPWongRHKet al.Calcium silicate-based cements: composition, properties, and clinical applications. J Investig Clin Dent2015, pp. 1–15.
27.
ColoradoHAWangZYangJM. Inorganic phosphate cement fabricated with wollastonite, barium titanate, and phosphoric acid. Cem Concr Compos2015; 62: 13–21.
28.
SopcakTMedveckyLGiretovaMet al.Phase transformations, microstructure formation and in vitro osteoblast response in calcium silicate/brushite cement composites. Biomed Mater2016; 11: 045013–045013.
29.
SoptrajanovBStefovVKuzmanovskiIet al.Fourier transform infrared and Raman spectra of manganese hydrogenphosphate trihydrate. J Mol Struct1999; 482–483: 103–107.
30.
SoptrajanovBJovanovskiGKuzmanovskiIet al.Fourier transform vibrational spectra of magnesium hydrogenphosphate trihydrate. I. The O–H stretching region. Spectros Lett1998; 31: 1191–1205.
31.
FTIR spectrum of wollastonite, NIST, Coblentz 4669.
32.
RutsteinMSWhiteWB. Vibrational spectra of high-calcium pyroxenes and pyroxenoids. Aam Min1971; 56: 877–887.
33.
InnocenziP. Infrared spectroscopy of sol–gel derived silica-based films: a spectra microstructure overview. J Non Cryst Solids2003; 316: 309–319.
34.
ShenNMatthewsMJElhadjSet al.Correlating optical damage threshold with intrinsic defect populations in fused silica as a function of heat treatment temperature. J Phys D Appl Phys2013; 46: 1–11.
35.
XieZWaltherJV. Dissolution stoichiometry and adsorption of alkali and alkaline earth elements to the acid-reacted wollastonite surface at 25℃. Geochim Cosmochim Acta1994; 58: 2587–2598.
36.
RimstidtJDDovePM. Mineral/solution reaction rates in a mixed flow reactor: Wollastonite hydrolysis. Geochim Cosmochim Acta1986; 50: 2509–2516.
37.
TayloraAWFraziereWGurneyanLet al.Solubility products of Di- and trimagnesium phosphates and the dissociation of magnesium phosphate solutions. Trans Faraday Soc1963; 59: 1585–1589.
38.
TamimiFNihouannenDLBassettDCet al.Biocompatibility of magnesium phosphate minerals and their stability under physiological conditions. Acta Biomater2011; 7: 2678–2685.
39.
BabaieELinBGoelVKet al.Evaluation of amorphous magnesium phosphate (AMP) based non-exothermic orthopedic cements. Biomed Mater2016; 11: 055010–055010.
40.
CombesCReyC. Amorphous calcium phosphates: synthesis, properties and uses in biomaterials. Acta Biomater2010; 6: 3362–3378.
41.
LayrollePItoATateishiT. Sol–gel synthesis of amorphous calcium phosphate and sintering into microporous hydroxyapatite bioceramics. J Am Ceram Soc1998; 81: 1421–1428.
42.
OstrowskiNSharmaVRoyAet al.Systematic assessment of synthesized tri-magnesium phosphate powders (amorphous, semi-crystalline and crystalline) and cements for ceramic bone cement applications. J Mater Sci Technol2015; 31: 437–444.
43.
FrostRLMartensWWilliamsPAet al.Raman and infrared spectroscopic study of the vivianite-group phosphates vivianite, baricite and bobierrite. Min Mag2002; 66: 1063–1073.
44.
AbbonaFBaronnetA. A XRD and TEM study on the transformation of amorphous calcium phosphate in the presence of magnesium. J Cryst Growth1996; 165: 98–105.
45.
HaddadAAZetiACA. Bioceramic-based root canal sealers: a review. Int J Biomater2016; 2016: 1–10.
46.
PinaSOlheroSMGheduzziSet al.Influence of setting liquid composition and liquid-to-powder ratio on properties of a Mg-substituted calcium phosphate cement. Acta Biomater2009; 5: 1233–1240.
47.
KhairounIBoltongMGDriessensFet al.Some factors controlling the injectability of calcium phosphate bone cements. J Mater Sci Mater M1998; 9: 425–438.
48.
DorozhkinSV. Calcium orthophosphate cements for biomedical application. J Mater Sci2008; 43: 3028–3057.
49.
LerouxLHatimZFrecheMet al.Effects of various adjuvants (lactic acid, glycerol and chitosan) on the injectability of a calcium phosphate cement. Bone1999; 25: 31–34.
50.
WuFSuJWeiJet al.Injectable bioactive calcium–magnesium phosphate cement for bone regeneration. Biomed Mater2008; 3: 044105–044105.
51.
JiaJZhouHWeiJet al.Development of magnesium calcium phosphate biocement for bone Regeneration. J R Soc Interface2010; 7: 1171–1180.
52.
HuanZChangJ. Novel bioactive composite bone cements based on the tricalcium phosphate – monocalcium phosphate monohydrate composite cement system. Acta Biomater2009; 5: 1253–1264.
53.
HuanZChangJ. Calcium–phosphate–silicate composite bone cement: self-setting properties and in vitro bioactivity. J Mater Sci Mater Med2009; 20: 833–841.
54.
WangXYeJWangYet al.Self-setting properties of a β-dicalcium silicate reinforced calcium phosphate cement. J Biomed Mater Res B Appl Biomater2007; 82B: 93–99.
55.
dos SantosEAFarinaMSoaresGAet al.Chemical and topographical influence of hydroxyapatite and β-tricalcium phosphate surfaces on human osteoblastic cell behavior. J Biomed Mater Res2009; 89: 510–520.
56.
HoppeAGüldalNSBoccacciniAR. A review of the biological response to ionic dissolution products from bioactive glasses and glass–ceramics. Biomaterials2011; 32: 2757–2774.
57.
MaenoSNikiYMatsumotoHet al.The effect of calcium ion concentration on osteoblast viability, proliferation and differentiation in monolayer and 3D culture. Biomaterials2005; 26: 4847–4855.
58.
ShieMYDingSJChangHC. The role of silicon in osteoblast-like cell proliferation and apoptosis. Acta Biomater2011; 7: 2604–2614.
59.
YangCYuanGZhangJet al.Effects of magnesium alloys extracts on adult human bone marrow-derived stromal cell viability and osteogenic differentiation. Biomed Mater2010; 5: 045005–045005.
60.
OkadaSItoHNagaiAet al.Adhesion of osteoblast-like cells on nanostructured hydroxyapatite. Acta Biomater2010; 6: 591–597.
